Marian Gorecki

2.6k total citations
63 papers, 2.2k citations indexed

About

Marian Gorecki is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Marian Gorecki has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Virology and 9 papers in Infectious Diseases. Recurrent topics in Marian Gorecki's work include HIV Research and Treatment (10 papers), RNA and protein synthesis mechanisms (9 papers) and HIV/AIDS drug development and treatment (8 papers). Marian Gorecki is often cited by papers focused on HIV Research and Treatment (10 papers), RNA and protein synthesis mechanisms (9 papers) and HIV/AIDS drug development and treatment (8 papers). Marian Gorecki collaborates with scholars based in Israel, United States and Canada. Marian Gorecki's co-authors include Meir Wilchek, Amos Panet, Boaz Amit, Shmuel Rozenblatt, A. Levanon, Alexander Rich, Elisha Zeelon, Robert W. Mahley, Karl H. Weisgraber and Nava Sarver and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Marian Gorecki

61 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marian Gorecki Israel 31 971 312 305 302 296 63 2.2k
Ronald L. Felsted United States 30 1.7k 1.8× 206 0.7× 369 1.2× 136 0.5× 131 0.4× 61 3.2k
Dennis E. Danley United States 31 2.7k 2.8× 282 0.9× 405 1.3× 129 0.4× 445 1.5× 52 4.1k
Richard C. Najarian United States 15 1.4k 1.4× 79 0.3× 316 1.0× 707 2.3× 265 0.9× 16 3.1k
Timothy K. Hart United States 19 903 0.9× 153 0.5× 157 0.5× 210 0.7× 121 0.4× 42 1.9k
Guy T. Mullenbach United States 25 1.4k 1.5× 62 0.2× 213 0.7× 642 2.1× 360 1.2× 39 3.3k
Kazuhisa Taketa Japan 27 2.0k 2.1× 90 0.3× 197 0.6× 1.1k 3.6× 563 1.9× 154 4.5k
S. Richard Jaskunas United States 29 3.3k 3.4× 164 0.5× 330 1.1× 580 1.9× 283 1.0× 55 4.9k
Balkrishen Bhat United States 34 3.3k 3.4× 100 0.3× 524 1.7× 434 1.4× 256 0.9× 94 4.6k
Rob Webster United Kingdom 17 705 0.7× 657 2.1× 527 1.7× 200 0.7× 67 0.2× 26 2.1k
Maurizio Cianfriglia Italy 29 1.3k 1.3× 215 0.7× 395 1.3× 140 0.5× 107 0.4× 100 2.5k

Countries citing papers authored by Marian Gorecki

Since Specialization
Citations

This map shows the geographic impact of Marian Gorecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian Gorecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian Gorecki more than expected).

Fields of papers citing papers by Marian Gorecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marian Gorecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian Gorecki. The network helps show where Marian Gorecki may publish in the future.

Co-authorship network of co-authors of Marian Gorecki

This figure shows the co-authorship network connecting the top 25 collaborators of Marian Gorecki. A scholar is included among the top collaborators of Marian Gorecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian Gorecki. Marian Gorecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorecki, Marian, et al.. (1999). Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine. 18(1-2). 3–17. 89 indexed citations
2.
Zeelon, Elisha, et al.. (1996). Ribonuclease H Activity during Initiation of Reverse Transcription Using tRNAlys/RNA Primer/Template of Human Immunodeficiency Virus. Archives of Biochemistry and Biophysics. 325(2). 209–216. 5 indexed citations
3.
Presley, John F., Marian Gorecki, Tikva Vogel, et al.. (1995). Effects of Apoprotein E on Intracellular Metabolism of Model Triglyceride-rich Particles Are Distinct from Effects on Cell Particle Uptake. Journal of Biological Chemistry. 270(4). 1761–1769. 56 indexed citations
4.
Fischer, Michael, et al.. (1995). Recombinant human acetylcholinesterase expressed in Escherichia coli: refolding, purification and characterization. Biotechnology and Applied Biochemistry. 21(3). 295–311. 12 indexed citations
5.
Margalit, Raanan, Heidi E. Drummer, Boaz Amit, et al.. (1994). Cellular Distribution of HIV Type 1 Nef Protein: Identification of Domains in Nef Required for Association with Membrane and Detergent-Insoluble Cellular Matrix. AIDS Research and Human Retroviruses. 10(8). 1003–1010. 50 indexed citations
7.
Granot, Esther, Ira Tabas, Marian Gorecki, et al.. (1994). Effects of Particle Size on Cell Uptake of Model Triglyceride-Rich Particles with and without Apoprotein E. Biochemistry. 33(50). 15190–15197. 34 indexed citations
9.
Fischer, Meir, et al.. (1993). Expression and reconstitution of biologically active human acetylcholinesterase fromEscherichia coli. Cellular and Molecular Neurobiology. 13(1). 25–38. 35 indexed citations
10.
Vogel, Thomas, Moshe M. Werber, Rachel Guy, et al.. (1993). Studies on Fibronectin and Its Domains. Archives of Biochemistry and Biophysics. 300(1). 501–509. 12 indexed citations
11.
Yao, S K, J C Ober, Amnon Gonenne, et al.. (1993). Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.. Circulation Research. 73(5). 952–967. 58 indexed citations
12.
Sarver, Nava, et al.. (1992). Molecular characterization of HIV1 nef protein. Research in Virology. 143(1). 50–52.
13.
Breuer, Raphael, Zelig Tochner, Michael W. Conner, et al.. (1992). Superoxide dismutase inhibits radiation-induced lung injury in hamsters. Lung. 170(1). 19–29. 19 indexed citations
14.
Zeelon, Elisha, et al.. (1992). Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases. Nucleic Acids Research. 20(19). 5115–5118. 30 indexed citations
15.
Fischer, Meir, et al.. (1992). Comparative analysis of native and cysteine-deficient HIV-1 reverse transcriptase. Protein Expression and Purification. 3(4). 301–307. 3 indexed citations
16.
Gorecki, Marian, Jacob R. Hartman, Meir Fischer, et al.. (1991). Recombinant Human Superoxide Dismutases: Production and Potential Therapeutical Uses. Free Radical Research Communications. 12(1). 401–410. 57 indexed citations
17.
Mahley, Robert W., et al.. (1989). Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.. Journal of Clinical Investigation. 83(6). 2125–2130. 95 indexed citations
18.
Amit, Boaz, et al.. (1987). Human Mn superoxide dismutase cDNA sequence. Nucleic Acids Research. 15(21). 9076–9076. 84 indexed citations
19.
Keshet, Eli, Arie Rosner, Yael Bernstein, Marian Gorecki, & Haim Aviv. (1981). Cloning of bovine growth hormone gene and its expression in bacteria. Nucleic Acids Research. 9(1). 19–30. 23 indexed citations
20.
Gorecki, Marian, Meir Wilchek, & Abraham Patchornik. (1971). The conversion of 3-monoazotyrosine to 3-aminotyrosine in peptides and proteins. Biochimica et Biophysica Acta (BBA) - Protein Structure. 229(3). 590–595. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026